Last year at about this time I would have said that, long term things looked great for this company. But my sentiment changed when there was nothing but silence following the Blackburn Nobel prize for telomere research. If there ever was a p/r horse to ride, that would have been it. Some creative writing by the (apparently) non-existant PR department could have brought this company's profile into the mainstream in a big way. Did not happen.

Then, as we are all only too aware, the FDA halts the Spinal Trial. And in the follow up we get the news that the resumption will happen in 9 or 10 months, while the lab rats are being tested. 9 months = (about) 30Million or so in cash burn. At 179 in the bank and no real news on the revenue stream from either Corning or GE.....that is NOT a hell of a lot of money.

In the mean time there are phase one trials with the telomere cancer programs.....all of which will be maturing in 2 years ....at best.

The likelyhood of this company getting out of the box they have created for themselves becomes more remote each day.
As the cash burns....and the trials lanquish....even the possibilty of a buy-out has slipped from the "25.00 range" down to 9 or 10.....again at best.

Frustration has given way to exhaustion and a very cynical view of both the management and the viability of this company.

But hey, that is just me.
In for a penny, in for a pound.
Holding until the cows come home.
Hopefully they will be here sooner rather than later.
But I am not counting on it.